AEP
45
5
SWK
53
4
EOG
28
2
ADBE
50
3
R
55
-2
GT
43
2
NTRS
35
10
MAS
46
3
WM
53
2
FITB
36
3
AAL
56
5
OXY
42
17
FOXA
67
5
AIZ
61
5
CTSH
55
3
IP
53
3
ITW
45
2
SBUX
29
-2
T
32
2
TGNA
48
5
AEP
45
5
SWK
53
4
EOG
28
2
ADBE
50
3
R
55
-2
GT
43
2
NTRS
35
10
MAS
46
3
WM
53
2
FITB
36
3
AAL
56
5
OXY
42
17
FOXA
67
5
AIZ
61
5
CTSH
55
3
IP
53
3
ITW
45
2
SBUX
29
-2
T
32
2
TGNA
48
5
Financhill
Back

Sumitomo Realty & Development Vs. Novo Nordisk AS Industry Stock Comparison

Buy
64

SURDF
Sumitomo Realty & Development

Last Price:
$31.59
Seasonality Move:
-2%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Buy
64
Sumitomo Realty & Development (SURDF) is a Buy

Is Sumitomo Realty & Development a Buy, Sell or Hold?

  • The current Sumitomo Realty & Development [SURDF] share price is $31.59. The Score for SURDF is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • SURDF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SURDF Stock Price Chart

What is Sumitomo Realty & Development's stock price today?

  • The Sumitomo Realty & Development share price today is $31.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SURDF is experiencing slight buying pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

SURDF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 67.23 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.51 - 31.49) Buy
Bollinger Bands (100): (30.15 - 33.61) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

SURDF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.49 Buy
20-day SMA: 30.66 Buy
50-day SMA: 30.88 Buy
200-day SMA: 32.59 Sell
8-day EMA: 31.44 Buy
20-day EMA: 31.05 Buy
50-day EMA: 31.18 Buy
200-day EMA: 31.47 Buy

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

Sumitomo Realty & Development Earnings Growth & SURDF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Sumitomo Realty & Development Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):